Literature DB >> 6132130

Relation of atrial fibrillation and high haematocrit to mortality in acute stroke.

G D Lowe, A J Jaap, C D Forbes.   

Abstract

Clinical and laboratory abnormalities and the presence of atrial fibrillation on admission were examined in relation to hospital mortality in a retrospective study of the 320 patients with acute stroke admitted to a medical unit in a 5-year period. Of clinical factors, only increasing age and the presence of coma were associated with mortality. Atrial fibrillation, present in 25% of all patients, was associated with an increased mortality in patients aged 60-79 years (67% vs 44%, p less than 0.01). In patients under 75 years the mortality associated with raised haematocrit (0.50 or more), present in 11% of all patients, was more than twice as high as it was in those with lower haematocrit (71% vs 31%, p less than 0.005). Other laboratory variables associated with a high mortality were increased levels of mean red cell volume, white cell count, erythrocyte sedimentation rate, globulin, and blood urea and creatinine; and decreased levels of albumin. The high prevalence of and increased mortality associated with atrial fibrillation and raised haematocrit in stroke patients indicate the need for further studies of stroke prevention and treatment in these patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132130     DOI: 10.1016/s0140-6736(83)91848-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Platelet activation, haemorheology and thrombogenesis in acute atrial fibrillation: a comparison with permanent atrial fibrillation.

Authors:  S Kamath; A D Blann; B S P Chin; G Y H Lip
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

2.  Antithrombotic treatment and atrial fibrillation.

Authors:  G D Lowe
Journal:  BMJ       Date:  1992-12-12

Review 3.  Red blood cell transfusion in the neurological ICU.

Authors:  Monisha A Kumar
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

4.  Relative erythrocytosis: an approach to the patient.

Authors:  F A Lederle
Journal:  J Gen Intern Med       Date:  1987 Mar-Apr       Impact factor: 5.128

5.  Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.

Authors:  K Kimura; K Minematsu; T Yamaguchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 6.  Red blood cell distribution width and cardiovascular diseases.

Authors:  Elisa Danese; Giuseppe Lippi; Martina Montagnana
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

7.  The prognostic value of blood glucose and glycosylated haemoglobin estimation in patients with stroke.

Authors:  N H Cox; J W Lorains
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

Review 8.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

Review 9.  Alternatives to warfarin for thromboembolism prophylaxis in nonrheumatic atrial fibrillation.

Authors:  Ramin Artang; Humberto Vidaillet
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 10.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.